Stock Analysis on Net
Stock Analysis on Net

Regeneron Pharmaceuticals Inc. (NASDAQ:REGN)

Analysis of Inventory

Microsoft Excel

Inventory Disclosure

Regeneron Pharmaceuticals Inc., balance sheet: inventory

US$ in thousands

Microsoft Excel
Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020
Raw materials 879,500 789,300 818,400 721,900 459,400
Work-in-process 1,342,300 1,121,800 963,100 707,200 904,600
Finished goods 139,800 147,300 98,600 73,700 121,700
Deferred costs 725,700 522,100 521,800 448,500 430,900
Inventories 3,087,300 2,580,500 2,401,900 1,951,300 1,916,600

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).

Item Description The company
Inventories Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer. Regeneron Pharmaceuticals Inc. inventories increased from 2022 to 2023 and from 2023 to 2024.